文献速递肥胖与代谢综合征

胃泌酸调节素和胰高血糖素样肽可能预测减重手术对食物偏好和体重减轻的效果

Oxyntomodulin and Glicentin May Predict the Effect of Bariatric Surgery on Food Preferences and Weight Loss.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

研究纳入42例重度肥胖受试者(32例RYGB,10例SG),测量术前和术后6个月餐后胃肠激素反应,评估与术后18个月体重减轻、能量摄入和食物偏好的关联。结果显示RYGB和SG术后胃泌酸调节素和胰高血糖素样肽反应增强可预测更好的体重减轻,并与能量密度降低相关。

要点

  • RYGB和SG术后餐后胃泌酸调节素和胰高血糖素样肽反应存在差异。
  • 胃泌酸调节素和胰高血糖素样肽反应增强预测更大幅度的体重减轻。
  • 这些激素反应增强与能量密度食物偏好降低相关。

核心结论

  • RYGB和SG术后餐后胃肠激素反应存在差异,胃泌酸调节素和胰高血糖素样肽反应增强预测更好的体重减轻并与能量密度食物偏好降低相关。

研究设计与样本

  • 研究纳入42例重度肥胖受试者(32例RYGB,10例SG),测量术前和术后6个月餐后胃肠激素反应,评估术后18个月体重减轻。

主要发现

  • RYGB和SG术后餐后胃泌酸调节素、胰高血糖素样肽、GLP-1和胃饥饿素浓度存在差异(所有P≤0.02)。
  • 胃泌酸调节素和胰高血糖素样肽反应增强预测更大幅度的体重减轻(均P<0.01),并与能量密度降低幅度更大相关(P≤0.04)。
  • GLP-1、PYY和胃饥饿素未发现上述关联,且激素变化与能量摄入变化无关。
  • 综合所有激素,可解释体重减轻变异的60%、能量摄入变异的19%和能量密度变异的33%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Alterations in several gastrointestinal hormones are implicated in the postoperative suppression of food intake leading to weight loss after Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG). The aim was to evaluate changes in responses of gastrointestinal hormones after RYGB and SG and the associations of these changes with weight loss, energy intake, and food preferences. METHODS: Forty-two subjects with severe obesity were included (32 RYGB; 10 SG). Postprandial responses of glicentin, oxyntomodulin, glucagon-like peptide-1 (GLP-1), peptide YY (PYY), and ghrelin were measured before and 6 months after surgery. Energy intake and energy density were assessed before and 6 months after surgery using a buffet meal test and weight loss was assessed 18 months after surgery. RESULTS: Postprandial concentrations of glicentin, oxyntomodulin, GLP-1, and ghrelin differed between RYGB and SG (all P ≤ .02). Enhanced responses of glicentin and oxyntomodulin predicted a greater weight loss (both P < .01) and were associated with a larger decrease in energy density (P ≤ .04). No associations were found for GLP-1, PYY, and ghrelin, and changes were not associated with changes in energy intake. When combing all hormones, 60%, 19%, and 33% of the variations in weight loss, energy intake, and energy density, respectively, could be explained. CONCLUSION: Postprandial responses of gastrointestinal hormones differed between RYGB and SG. Enhanced responses of glicentin and oxyntomodulin predicted a better weight loss and were associated with a decreased preference for energy-dense foods. Replication of these results could imply an opportunity to identify patients in need of additional support after surgical treatments of obesity.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Nielsen MS, Ritz C, Wewer Albrechtsen NJ, et al. Oxyntomodulin and Glicentin May Predict the Effect of Bariatric Surgery on Food Preferences and Weight Loss. J Clin Endocrinol Metab. 2020. PMID: 32016415. doi:10.1210/clinem/dgaa061

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。